PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March
PRINCETON, N.J., Feb. 28, 2023 -- PMV Pharmaceuticals, Inc. , a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53, today... | February 28, 2023
Source: marketscreener.com